CETP Lowers TLR4 Expression Which Attenuates the Inflammatory Response Induced by LPS and Polymicrobial Sepsis

Tatiana Martins Venancio1, Roberta Marcondes Machado1, Angela Castoldi2

  • 1Lipids Laboratory (LIM 10), Faculty of Medical Sciences, The University of São Paulo, São Paulo, SP, Brazil.

Insights

Cholesteryl ester transfer protein (CETP) enhances survival in sepsis by reducing inflammation. Lowering CETP may be detrimental for sepsis and infectious diseases.

Area of Science:

  • Immunology
  • Biochemistry
  • Pathophysiology

Background:

  • Sepsis is a life-threatening systemic inflammatory response to infection with high mortality.
  • Mechanisms underlying sepsis pathogenesis remain incompletely understood, necessitating novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of cholesteryl ester transfer protein (CETP) in modulating the inflammatory response during sepsis.
  • To evaluate the impact of CETP on survival rates and inflammatory profiles in a murine sepsis model.

Main Methods:

  • Polymicrobial sepsis was induced in human CETP transgenic mice and wild-type (WT) control mice using cecal ligation and puncture (CLP).
  • Peritoneal macrophages were isolated and stimulated with lipopolysaccharide (LPS) with or without recombinant CETP for phenotypic and functional analyses.

Main Results:

  • CETP transgenic mice exhibited significantly higher survival rates compared to WT mice post-CLP.
  • Lower plasma concentrations of interleukin-6 (IL-6) and reduced hepatic expression of toll-like receptor 4 (TLR4) and acyloxyacyl hydrolase (AOAH) were observed in CETP mice.
  • Recombinant CETP treatment decreased LPS uptake, TLR4 expression, NF-κB activation, and IL-6 secretion in WT macrophages.

Conclusions:

  • CETP plays a protective role in sepsis, attenuating the inflammatory response and improving survival.
  • Pharmacological inhibition of CETP might be disadvantageous in managing sepsis and other infectious diseases.